Editas Medicine (EDIT) Change in Cash (2015 - 2025)
Editas Medicine (EDIT) reported Change in Cash of $25.9 million for Q3 2025, down 17.5% year-over-year from $31.4 million in Q3 2024, and up 17366.0% on a QoQ basis from -$150000.0 in Q2 2025.
Editas Medicine (EDIT) has 11 years of Change in Cash data on file, last reported at $25.9 million in Q3 2025.
- Quarterly Change in Cash fell 17.5% year-over-year to $25.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $68.6 million (up 416.09% YoY) and the FY2024 annual result came in at $7.9 million, up 144.15% from the prior year.
- Change in Cash advanced to $25.9 million in Q3 2025 per EDIT's latest filing, from -$150000.0 in the prior quarter.
- Across five years, Change in Cash topped out at $215.2 million in Q1 2021 and bottomed at -$138.3 million in Q3 2023.
- The 5-year median for Change in Cash is -$150000.0 (2025), against an average of $1.3 million.
- The widest annual swing landed in 2021, when Change in Cash jumped 4804.61%; it then slumped 434.79% in 2023.
- Tracing EDIT's Change in Cash over 5 years: stood at -$56.4 million in 2021, then decreased by 22.74% to -$69.2 million in 2022, then surged by 159.43% to $41.1 million in 2023, then fell by 13.15% to $35.7 million in 2024, then slipped by 27.47% to $25.9 million in 2025.
- Per Business Quant, the three latest EDIT Change in Cash figures stand at $25.9 million (Q3 2025), -$150000.0 (Q2 2025), and $7.2 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 25.90 Mn |
| Jun 30, 2025 | -150,000.00 |
| Mar 31, 2025 | 7.15 Mn |
| Dec 31, 2024 | 35.71 Mn |
| Sep 30, 2024 | 31.39 Mn |
| Jun 30, 2024 | -4.79 Mn |
| Mar 31, 2024 | -54.43 Mn |
| Dec 31, 2023 | 41.11 Mn |
| Sep 30, 2023 | -138.28 Mn |
| Jun 30, 2023 | 91.80 Mn |
| Mar 31, 2023 | -12.50 Mn |
| Dec 31, 2022 | -69.18 Mn |
| Sep 30, 2022 | 41.30 Mn |
| Jun 30, 2022 | -41.48 Mn |
| Mar 31, 2022 | 7.36 Mn |
| Dec 31, 2021 | -56.37 Mn |
| Sep 30, 2021 | -77.95 Mn |
| Jun 30, 2021 | -17.08 Mn |
| Mar 31, 2021 | 215.24 Mn |
| Dec 31, 2020 | -139.89 Mn |
| Sep 30, 2020 | -206.24 Mn |
| Jun 30, 2020 | 254.47 Mn |
| Mar 31, 2020 | -4.58 Mn |
| Dec 31, 2019 | 133.41 Mn |
| Sep 30, 2019 | -105.83 Mn |
| Jun 30, 2019 | 52.67 Mn |
| Mar 31, 2019 | 23.16 Mn |
| Dec 31, 2018 | 23.08 Mn |
| Sep 30, 2018 | -20.22 Mn |
| Jun 30, 2018 | -85.75 Mn |
| Mar 31, 2018 | 71.04 Mn |
| Sep 30, 2017 | -98.78 Mn |
| Jun 30, 2017 | -41.23 Mn |
| Mar 31, 2017 | 166.23 Mn |
| Dec 31, 2016 | -13.25 Mn |
| Sep 30, 2016 | -17.78 Mn |
| Jun 30, 2016 | -11.55 Mn |
| Mar 31, 2016 | 86.02 Mn |
| Dec 31, 2015 | -12.16 Mn |
| Sep 30, 2015 | 108.26 Mn |
| Jun 30, 2015 | 41.87 Mn |
| Mar 31, 2015 | -5.46 Mn |